AR050010A1 - WATER SOLUBLE RECYCLED HIALURONIC ACID, ITS PREPARATION PROCEDURE, IMPLANTATION CONTAINING SUCH RETICULATED HIALURONIC ACID, AND ITS USE - Google Patents

WATER SOLUBLE RECYCLED HIALURONIC ACID, ITS PREPARATION PROCEDURE, IMPLANTATION CONTAINING SUCH RETICULATED HIALURONIC ACID, AND ITS USE

Info

Publication number
AR050010A1
AR050010A1 ARP050103044A AR050010A1 AR 050010 A1 AR050010 A1 AR 050010A1 AR P050103044 A ARP050103044 A AR P050103044A AR 050010 A1 AR050010 A1 AR 050010A1
Authority
AR
Argentina
Prior art keywords
hialuronic acid
water soluble
reticulated
recycled
acid
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Asius Jerome
Asius Benedicte
Riviere Nicolas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asius Jerome, Asius Benedicte, Riviere Nicolas filed Critical Asius Jerome
Publication of AR050010A1 publication Critical patent/AR050010A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente tiene por objeto un ácido hialuronico reticulado que presenta solubilidad en agua y que es susceptible de ser obtenido por un procedimiento de preparacion que comprende la puesta en contacto en un medio acuoso de por lo menos un ácido hialuronico o una de sus sales, y por lo menos un agente reticulante que comprende por lo menos un oligopéptido o polipéptido que poseen por lo menos dos, de preferencia, por lo menos cinco unidades lisina, donde dicha puesta en contacto se efectua en presencia de por lo menos un agente de acoplamiento hidrosoluble y de por lo menos un catalizador. La presente se refiere también a un implanto que contiene dicho ácido hialuronico reticulado, y a su utilizacion en medicina humana o veterinaria, en particular en cirugía reparadora y/o estética.The present object is a crosslinked hyaluronic acid that has water solubility and is capable of being obtained by a preparation process comprising contacting in an aqueous medium of at least one hyaluronic acid or one of its salts, and at least one crosslinking agent comprising at least one oligopeptide or polypeptide having at least two, preferably, at least five lysine units, wherein said contacting is effected in the presence of at least one water soluble coupling agent and of at least one catalyst. This also refers to an implant containing said cross-linked hyaluronic acid, and its use in human or veterinary medicine, in particular in restorative and / or cosmetic surgery.

ARP050103044 2004-07-23 2005-07-22 WATER SOLUBLE RECYCLED HIALURONIC ACID, ITS PREPARATION PROCEDURE, IMPLANTATION CONTAINING SUCH RETICULATED HIALURONIC ACID, AND ITS USE AR050010A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408199A FR2873379B1 (en) 2004-07-23 2004-07-23 PROCESS FOR THE PREPARATION OF RETICULATED HYALURONIC ACID, RETICULATED HYALURONIC ACID WHICH CAN BE OBTAINED BY THIS METHOD, IMPLANT CONTAINING THE RETICULATED HYALURONIC ACID, AND USE THEREOF

Publications (1)

Publication Number Publication Date
AR050010A1 true AR050010A1 (en) 2006-09-20

Family

ID=34953044

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103044 AR050010A1 (en) 2004-07-23 2005-07-22 WATER SOLUBLE RECYCLED HIALURONIC ACID, ITS PREPARATION PROCEDURE, IMPLANTATION CONTAINING SUCH RETICULATED HIALURONIC ACID, AND ITS USE

Country Status (3)

Country Link
AR (1) AR050010A1 (en)
FR (1) FR2873379B1 (en)
WO (1) WO2006021644A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100273734A1 (en) * 2006-02-28 2010-10-28 Novozymes Biopolymer A/S Derivatives of Hyaluronic Acids
FR2908415B1 (en) 2006-11-10 2009-01-23 Abr Dev Sarl RETICULATED HYALURONIC ACID AND PROCESS FOR PREPARING THE SAME
FR2909560B1 (en) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique HYALURONIC ACID GEL FOR INTRADERMAL INJECTION
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
HUE030138T2 (en) 2010-03-22 2017-04-28 Allergan Inc Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
WO2012167079A2 (en) 2011-06-03 2012-12-06 Allergan, Inc. Dermal filler compositions including antioxidants
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
CN104105474B (en) * 2011-09-14 2018-04-06 阿勒根公司 Dermal augmentation agent composition for microgroove treatment
PL3175840T3 (en) * 2011-12-08 2021-01-25 Allergan Industrie, Sas Dermal filler compositions
GB2501943B (en) * 2012-05-10 2020-09-23 Zeiss Carl Meditec Ag Ophthalmic viscoelastic device
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
EP3620184A1 (en) 2014-09-30 2020-03-11 Allergan Industrie, SAS Stable hydrogel compositions including additives
US10300169B2 (en) 2016-08-24 2019-05-28 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
US11732093B2 (en) 2017-07-26 2023-08-22 Polypeptide Therapeutic Solutions S.L. Cross polymers composed of polysaccharides and polyamino acids, and uses thereof
FR3095206B1 (en) * 2019-04-17 2021-11-05 Lab Vivacy POLYMER CROSS-LINKING PROCESS
CN111732741B (en) * 2020-06-24 2023-04-25 华熙生物科技股份有限公司 Method for crosslinking hyaluronic acid and epsilon-polylysine, composite crosslinked product obtained by method and application of composite crosslinked product
CN115944553A (en) * 2022-12-07 2023-04-11 华熙生物科技股份有限公司 Application of oligopeptide in improving stability of cross-linked hyaluronic acid or salt thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
FR2752843B1 (en) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic CROSSLINKED COPOLYMERS BASED ON POLYCARBOXYLIC POLYMERS AND THEIR USE AS SUPPORTS OF PHARMACEUTICAL COMPOSITIONS
FR2754828B1 (en) * 1996-10-23 1998-12-24 Univ Toulouse ARTIFICIAL MEMBRANE STRUCTURE, METHOD AND POLYMER FOR PREPARING IT, METHOD FOR PREPARING THIS POLYMER, PARTICLE AND FILM COMPRISING THIS STRUCTURE
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
FR2793693A3 (en) * 1999-05-18 2000-11-24 Martine Bulette Vascular prosthesis is made of base material, optionally textile, impregnated with bio-polymer of vegetable origin to make it impermeable to blood
US20060094643A1 (en) * 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
EP1535952B1 (en) * 2003-11-28 2013-01-16 Universite Louis Pasteur Method for preparing crosslinked polyelectrolyte multilayer films

Also Published As

Publication number Publication date
FR2873379B1 (en) 2008-05-16
WO2006021644A1 (en) 2006-03-02
FR2873379A1 (en) 2006-01-27

Similar Documents

Publication Publication Date Title
AR050010A1 (en) WATER SOLUBLE RECYCLED HIALURONIC ACID, ITS PREPARATION PROCEDURE, IMPLANTATION CONTAINING SUCH RETICULATED HIALURONIC ACID, AND ITS USE
KR102242894B1 (en) How to suppress off-flavor
ATE243720T1 (en) HYDROGEL-FORMING, SELF-SOLVATIZING, ABSORBABLE POLYESTER COPOLYMERS AND METHOD FOR THE USE THEREOF
JP2018504167A5 (en)
BRPI0508349B8 (en) a method of determining a refractive treatment format to improve a patient's vision condition; and, a system for generating a refractive treatment format to improve a patient's vision condition in a patient's eye.
WO2006041942A3 (en) Ocular delivery of polymeric delivery formulations
DE69929278D1 (en) Hydrogel-forming, self-solvating, absorbable polyester copolymers and methods for their use
DE122005000001I2 (en) Divalent metal salts of 2-N, N-di (carboxymethyl) amino-3-cyano-4-carboxymethyl-5-carboxy-thiophenic acid, processes for their preparation and pharmaceutical compositions containing them
DE69029257D1 (en) ARRANGEMENT FOR RADIATION OF LASER RAYS
CL2004001642A1 (en) USE OF A HYDROLYZE OF USEFUL FISH PROTEIN TO ELABORATE PHARMACEUTICAL AND NUTRITIONAL COMPOSITIONS, METHOD OF ELABORATION OF THE HYDROLYZED SUCH.
DK0590015T3 (en) A tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
DE60311692D1 (en) Vascular treatment device
DE60236413D1 (en) INHIBITORS OF HMGB1 FOR THE TREATMENT OF TISSUE DISEASES
BR9814217A (en) Super absorbent gels based on poly (vinylguanidine)
DK1450771T3 (en) Pharmaceutical compositions for treating skin lesions and mucous membranes and methods and kits for their use
ES2194727T3 (en) THREE-DIMENSIONAL STRUCTURES CONTAINING DERIVATIVES OF THE HIALURONIC ACID OBTAINED BY THE SUPERCRITICAL ANTIDISOLVENT TECHNIQUE.
Huang et al. Pincer nail deformity: clinical characteristics, causes, and managements
ATE449612T1 (en) COMPOSITION FOR VACCINATION
ES2860683T3 (en) Wound dressing
BR0016304A (en) Formulation of aqueous stable interferon solution, preparation method and uses for it
US8889626B2 (en) Triple cross-linked collagen, method of manufacturing the same, and use thereof
DE60011062D1 (en) METHOD FOR THE PRODUCTION OF SELF-CROSS-LINKED HYALURONIC ACIDS AND THEIR DERIVATIVES BY MEANS OF SUPERCRITICAL ANTI-SOLVENTS
ES2786259T3 (en) Controllable Degradable Compositions and Methods
ES2858519T3 (en) Method to increase the yield of collagen, and collagen prepared with said method
BR0209846B1 (en) use of an agent obtained by artificial UV irradiation of an aqueous solution for sterilization treatment of medical instruments.

Legal Events

Date Code Title Description
FB Suspension of granting procedure